3-Fluoro-4-methoxyaniline

We are 3-Fluoro-4-methoxyaniline CAS:366-99-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:    3-Fluoro-4-methoxyaniline
CAS.NO: 366-99-4
Synonyms:4-Amino-2-fluoro-1-methoxybenzene;
3-fluor-4-methoxyanilin;
2-FLUORO-4-AMINOANISOLE;
4-Amino-2-fluoroanisole;
3-FLUORO-4-METHOXY-BENZENAMINE;
Molecular Formula:  C7H8FNO
Molecular Weight: 141.14300
 
Physical and Chemical Properties:
Density: 1.176g/cm3
Melting point: 81-83 °C
Boiling point: 135 °C18 mm Hg(lit.)
Flash point:  >110°C
Index of Refraction:1.531
 
Specification:
Appearance: White Crystalline Powder
Purity:≥99.0%
 
Packing:25kg/drum
Storage:Keep away from heat, sparks, and flame. Keep away from sources of ignition. Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.
Application:     used in the Pharmaceutical Industrial

3-Fluoro-4-methoxyaniline


Related News: As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.L-4-Nitrophenylalanine methyl ester hydrochloride CAS:17193-40-7 As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.98-01-1 Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.65-22-5 Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.Pre-approval Access Programs (also known as expanded access, early access, compassionate use, named patient supply) are regulatory-compliant processes permitting experimental agents in development to be made available upon the request of a physician or a patient for appropriate patients for whom no alternative treatment option exists in their country.

Related Products
Product Name
Propyl Gallate View Details
4′-N-OCTYLACETOPHENONE View Details
4-Bromo-3-chlorobenzotrifluoride View Details
Tris(2-chloroethyl) Phosphite manufacturer 3-tri(propan-2-yloxy)silylpropyl 2-methylprop-2-enoate manufacturer 2-(p-chlorophenyl)-1-methyl-5-(trifluoromethyl)-2-pyrroline-3-carbonitrile manufacturer ethyl 4,4,4-trifluoro-3-methylbutanoate Cas:6975-13-9 manufacturer N-methylformamide manufacturer